Drug interactions
Desogestrel-ethinyl estradiol + Somapacitan
Severity: Moderate
Desogestrel-ethinyl estradiol and Somapacitan: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Oral estrogens reduce hepatic IGF-1 production in response to growth hormone, which blunts the effect of growth hormone analogs. Patients may need higher doses of somapacitan to reach IGF-1 targets.
What this interaction means in plain words
Desogestrel-ethinyl estradiol and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Desogestrel-ethinyl estradiol belongs to Endocrine; Somapacitan belongs to Endocrine.
Why it happens
Oral estrogen first-pass effect on the liver antagonizes growth hormone signaling and lowers IGF-1 generation.
What to do
Monitor IGF-1 and clinical response, and titrate the somapacitan dose accordingly. Consider a transdermal estrogen if feasible.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Desogestrel-ethinyl estradiol and Somapacitan, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Desogestrel-ethinyl estradiol
- Desogestrel-ethinyl estradiol + Fezolinetant Contraindicated
- Aminocaproic acid + Desogestrel-ethinyl estradiol Major
- Amobarbital + Desogestrel-ethinyl estradiol Major
- Anastrozole + Desogestrel-ethinyl estradiol Major
- Apalutamide + Desogestrel-ethinyl estradiol Major
- Atazanavir + Desogestrel-ethinyl estradiol Major
Other interactions of Somapacitan
- Alogliptin-metformin + Somapacitan Moderate
- Alogliptin-pioglitazone + Somapacitan Moderate
- Alogliptin + Somapacitan Moderate
- Bazedoxifene-conjugated estrogens + Somapacitan Moderate
- Canagliflozin-metformin + Somapacitan Moderate
- Chlorpropamide + Somapacitan Moderate
Frequently asked questions
Can I take Desogestrel-ethinyl estradiol with Somapacitan?
MediHelp rates the interaction as moderate. Desogestrel-ethinyl estradiol and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oral estrogens reduce hepatic IGF-1 production in response to growth hormone, which blunts the effect of growth hormone analogs. Patients may need higher doses of somapacitan to reach IGF-1 targets.
How serious is the interaction between Desogestrel-ethinyl estradiol and Somapacitan?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor IGF-1 and clinical response, and titrate the somapacitan dose accordingly. Consider a transdermal estrogen if feasible.
What other medicines interact with Desogestrel-ethinyl estradiol?
MediHelp also lists interactions of Desogestrel-ethinyl estradiol with, for example, Fezolinetant, Aminocaproic acid, Amobarbital. The full list is on the Desogestrel-ethinyl estradiol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
